High-risk patients for carotid endarterectomy: The candidates for carotid angioplasty and stent placement

Ricardo A. Hanel, Andrew R. Xavier, Amir M. Siddiqui, Jawad F. Kirmani, Bernard Bendok, Stanley H. Kim, Abutaher M. Yahia, L. N. Hopkins, Adnan I. Qureshi

Research output: Contribution to journalArticle

Abstract

Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer.1,2 Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. By the year 2050, an estimated 1 million persons will suffer from stroke every year due to changes in age and ethnic distribution.3 Approximately 25% of these ischemic events are related to occlusive disease of the cervical internal carotid artery.4 Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source and/or causing hypoperfusion of the ipsilateral cerebral hemisphere. Carotid endarterectomy (CEA), first performed by DeBakey in 1953,5 involves arteriotomy of the cervical carotid artery with subsequent removal of athersclerotic plaque. This procedure has been shown to substantially reduce the risk of stroke associated with high-grade carotid stenosis.6-8 During the last few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particularly in patients who are known to have a higher complication rate with CEA.9,10 The aim of this paper is to briefly review the indications and limitations of CEA, and show how CAS could be a safe and viable alternative in the management of high-risk CEA candidates.

Original languageEnglish (US)
Pages (from-to)257-263
Number of pages7
JournalSeminars in Neurosurgery
Volume13
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Carotid Endarterectomy
Angioplasty
Stents
Stroke
Carotid Stenosis
Risk Management
Cerebrum
Carotid Arteries
Cause of Death
Heart Diseases
Costs and Cost Analysis

Keywords

  • Angioplasty
  • Carotid artery disease
  • High-risk patients
  • Stent

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Hanel, R. A., Xavier, A. R., Siddiqui, A. M., Kirmani, J. F., Bendok, B., Kim, S. H., ... Qureshi, A. I. (2002). High-risk patients for carotid endarterectomy: The candidates for carotid angioplasty and stent placement. Seminars in Neurosurgery, 13(3), 257-263. https://doi.org/10.1055/s-2002-39819

High-risk patients for carotid endarterectomy : The candidates for carotid angioplasty and stent placement. / Hanel, Ricardo A.; Xavier, Andrew R.; Siddiqui, Amir M.; Kirmani, Jawad F.; Bendok, Bernard; Kim, Stanley H.; Yahia, Abutaher M.; Hopkins, L. N.; Qureshi, Adnan I.

In: Seminars in Neurosurgery, Vol. 13, No. 3, 2002, p. 257-263.

Research output: Contribution to journalArticle

Hanel, RA, Xavier, AR, Siddiqui, AM, Kirmani, JF, Bendok, B, Kim, SH, Yahia, AM, Hopkins, LN & Qureshi, AI 2002, 'High-risk patients for carotid endarterectomy: The candidates for carotid angioplasty and stent placement', Seminars in Neurosurgery, vol. 13, no. 3, pp. 257-263. https://doi.org/10.1055/s-2002-39819
Hanel, Ricardo A. ; Xavier, Andrew R. ; Siddiqui, Amir M. ; Kirmani, Jawad F. ; Bendok, Bernard ; Kim, Stanley H. ; Yahia, Abutaher M. ; Hopkins, L. N. ; Qureshi, Adnan I. / High-risk patients for carotid endarterectomy : The candidates for carotid angioplasty and stent placement. In: Seminars in Neurosurgery. 2002 ; Vol. 13, No. 3. pp. 257-263.
@article{5b81656d1dea4766852c043ada1fe6a9,
title = "High-risk patients for carotid endarterectomy: The candidates for carotid angioplasty and stent placement",
abstract = "Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer.1,2 Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. By the year 2050, an estimated 1 million persons will suffer from stroke every year due to changes in age and ethnic distribution.3 Approximately 25{\%} of these ischemic events are related to occlusive disease of the cervical internal carotid artery.4 Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source and/or causing hypoperfusion of the ipsilateral cerebral hemisphere. Carotid endarterectomy (CEA), first performed by DeBakey in 1953,5 involves arteriotomy of the cervical carotid artery with subsequent removal of athersclerotic plaque. This procedure has been shown to substantially reduce the risk of stroke associated with high-grade carotid stenosis.6-8 During the last few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particularly in patients who are known to have a higher complication rate with CEA.9,10 The aim of this paper is to briefly review the indications and limitations of CEA, and show how CAS could be a safe and viable alternative in the management of high-risk CEA candidates.",
keywords = "Angioplasty, Carotid artery disease, High-risk patients, Stent",
author = "Hanel, {Ricardo A.} and Xavier, {Andrew R.} and Siddiqui, {Amir M.} and Kirmani, {Jawad F.} and Bernard Bendok and Kim, {Stanley H.} and Yahia, {Abutaher M.} and Hopkins, {L. N.} and Qureshi, {Adnan I.}",
year = "2002",
doi = "10.1055/s-2002-39819",
language = "English (US)",
volume = "13",
pages = "257--263",
journal = "Seminars in Neurosurgery",
issn = "1526-8012",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - High-risk patients for carotid endarterectomy

T2 - The candidates for carotid angioplasty and stent placement

AU - Hanel, Ricardo A.

AU - Xavier, Andrew R.

AU - Siddiqui, Amir M.

AU - Kirmani, Jawad F.

AU - Bendok, Bernard

AU - Kim, Stanley H.

AU - Yahia, Abutaher M.

AU - Hopkins, L. N.

AU - Qureshi, Adnan I.

PY - 2002

Y1 - 2002

N2 - Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer.1,2 Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. By the year 2050, an estimated 1 million persons will suffer from stroke every year due to changes in age and ethnic distribution.3 Approximately 25% of these ischemic events are related to occlusive disease of the cervical internal carotid artery.4 Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source and/or causing hypoperfusion of the ipsilateral cerebral hemisphere. Carotid endarterectomy (CEA), first performed by DeBakey in 1953,5 involves arteriotomy of the cervical carotid artery with subsequent removal of athersclerotic plaque. This procedure has been shown to substantially reduce the risk of stroke associated with high-grade carotid stenosis.6-8 During the last few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particularly in patients who are known to have a higher complication rate with CEA.9,10 The aim of this paper is to briefly review the indications and limitations of CEA, and show how CAS could be a safe and viable alternative in the management of high-risk CEA candidates.

AB - Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer.1,2 Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. By the year 2050, an estimated 1 million persons will suffer from stroke every year due to changes in age and ethnic distribution.3 Approximately 25% of these ischemic events are related to occlusive disease of the cervical internal carotid artery.4 Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source and/or causing hypoperfusion of the ipsilateral cerebral hemisphere. Carotid endarterectomy (CEA), first performed by DeBakey in 1953,5 involves arteriotomy of the cervical carotid artery with subsequent removal of athersclerotic plaque. This procedure has been shown to substantially reduce the risk of stroke associated with high-grade carotid stenosis.6-8 During the last few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particularly in patients who are known to have a higher complication rate with CEA.9,10 The aim of this paper is to briefly review the indications and limitations of CEA, and show how CAS could be a safe and viable alternative in the management of high-risk CEA candidates.

KW - Angioplasty

KW - Carotid artery disease

KW - High-risk patients

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=0038410166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038410166&partnerID=8YFLogxK

U2 - 10.1055/s-2002-39819

DO - 10.1055/s-2002-39819

M3 - Article

AN - SCOPUS:0038410166

VL - 13

SP - 257

EP - 263

JO - Seminars in Neurosurgery

JF - Seminars in Neurosurgery

SN - 1526-8012

IS - 3

ER -